NAD+ biosynthesis and mitochondrial repair in acute kidney injury via ultrasound-responsive thylakoid-integrating liposomes

IF 26.8 1区 医学 Q1 ENGINEERING, BIOMEDICAL
Yao Lei, Yuzhu Wu, Wan-Ru Zhuang, Helin Zhao, Weidong Nie, Guanghao Wu, Dai-Wen Pang, Hai-Yan Xie
{"title":"NAD+ biosynthesis and mitochondrial repair in acute kidney injury via ultrasound-responsive thylakoid-integrating liposomes","authors":"Yao Lei, Yuzhu Wu, Wan-Ru Zhuang, Helin Zhao, Weidong Nie, Guanghao Wu, Dai-Wen Pang, Hai-Yan Xie","doi":"10.1038/s41551-025-01402-y","DOIUrl":null,"url":null,"abstract":"<p>Acute kidney injury (AKI) impairs the energy metabolism and antioxidant capacity of renal proximal tubular cells. Here we show that ultrasound-responsive liposomes integrating thylakoid fragments and encapsulating <span>l</span>-ascorbic acid can restore the energy supply and antioxidant capacity of the tubular cells as well as renal function in animal models of AKI. After intravenous injection, the liposomes preferentially accumulated in the injured kidneys and were internalized by proximal tubular cells. Quinolinate phosphoribosyltransferase expressed in thylakoid catalysed the biosynthesis of nicotinamide adenine dinucleotide (NAD<sup>+</sup>), prompting the recovery of damaged mitochondria. Local ultrasound stimulation activated electron transfer from ascorbic acid, which led to the cytoplasmic formation of NADH and to the restoration of adenosine triphosphate through the malate-aspartate shuttle. Concurrently, the enhanced pentose phosphate pathway facilitated NADPH biosynthesis and reduced the levels of reactive oxygen species. In mice and piglets with AKI, low doses of the liposomes prevented kidney damage.</p>","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":"168 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1038/s41551-025-01402-y","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Acute kidney injury (AKI) impairs the energy metabolism and antioxidant capacity of renal proximal tubular cells. Here we show that ultrasound-responsive liposomes integrating thylakoid fragments and encapsulating l-ascorbic acid can restore the energy supply and antioxidant capacity of the tubular cells as well as renal function in animal models of AKI. After intravenous injection, the liposomes preferentially accumulated in the injured kidneys and were internalized by proximal tubular cells. Quinolinate phosphoribosyltransferase expressed in thylakoid catalysed the biosynthesis of nicotinamide adenine dinucleotide (NAD+), prompting the recovery of damaged mitochondria. Local ultrasound stimulation activated electron transfer from ascorbic acid, which led to the cytoplasmic formation of NADH and to the restoration of adenosine triphosphate through the malate-aspartate shuttle. Concurrently, the enhanced pentose phosphate pathway facilitated NADPH biosynthesis and reduced the levels of reactive oxygen species. In mice and piglets with AKI, low doses of the liposomes prevented kidney damage.

Abstract Image

超声响应类囊体整合脂质体对急性肾损伤NAD+生物合成和线粒体修复的影响
急性肾损伤(AKI)损害肾近端小管细胞的能量代谢和抗氧化能力。本研究表明,整合类囊体碎片并包封l-抗坏血酸的超声响应脂质体可以恢复AKI动物模型小管细胞的能量供应和抗氧化能力以及肾功能。经静脉注射后,脂质体优先积聚在受损肾脏,并被近端肾小管细胞内化。类囊体中表达的喹啉酸磷酸核糖基转移酶催化了烟酰胺腺嘌呤二核苷酸(NAD+)的生物合成,促进了受损线粒体的恢复。局部超声刺激激活抗坏血酸的电子转移,导致细胞质形成NADH,并通过苹果酸-天冬氨酸穿梭恢复三磷酸腺苷。同时,戊糖磷酸途径的增强促进了NADPH的生物合成,降低了活性氧的水平。在患有AKI的小鼠和仔猪中,低剂量的脂质体可以防止肾脏损伤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nature Biomedical Engineering
Nature Biomedical Engineering Medicine-Medicine (miscellaneous)
CiteScore
45.30
自引率
1.10%
发文量
138
期刊介绍: Nature Biomedical Engineering is an online-only monthly journal that was launched in January 2017. It aims to publish original research, reviews, and commentary focusing on applied biomedicine and health technology. The journal targets a diverse audience, including life scientists who are involved in developing experimental or computational systems and methods to enhance our understanding of human physiology. It also covers biomedical researchers and engineers who are engaged in designing or optimizing therapies, assays, devices, or procedures for diagnosing or treating diseases. Additionally, clinicians, who make use of research outputs to evaluate patient health or administer therapy in various clinical settings and healthcare contexts, are also part of the target audience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信